Clusterin: A Marker and Mediator of Chemoresistance in Colorectal Cancer

0
27
Scientists discuss recent insights on clusterin (CLU) in colorectal cancer and its roles in enhancing the plasticity of cells and further consider the implications of CLU as a prospective target for therapeutic intervention.
[Cancer and Metastasis Reviews]
Full Article